@ibdseb @DCharabaty @MondayNightIBD Although studies showed high placebo response, JAK inhibitors like Tofacitinib can have a role in Crohn's. In a study on safety profile of tofacitinib in children with juvenile arthritis,tofacitinib 5 mg BID was generall
RT @GEFP_SEFH: "Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: resu…
"Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study" https://t.co/SFwVgv7nMc #pediatria